Baillie Gifford - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 230 filers reported holding BEAM THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.

Quarter-by-quarter ownership
Baillie Gifford ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$21,061,716
+25.9%
875,747
+67.2%
0.02%
+35.7%
Q2 2023$16,722,794
+20.6%
523,733
+15.7%
0.01%
+7.7%
Q1 2023$13,863,542
-22.1%
452,761
-0.5%
0.01%
-31.6%
Q4 2022$17,788,324
-3.1%
454,828
+18.1%
0.02%0.0%
Q3 2022$18,351,000
+4343.3%
385,218
+3509.3%
0.02%
Q2 2022$413,000
-32.5%
10,6730.0%0.00%
Q1 2022$612,000
-28.1%
10,6730.0%0.00%
Q4 2021$851,000
-8.6%
10,673
-0.3%
0.00%
Q3 2021$931,000
+1377.8%
10,700
+2097.1%
0.00%
Q2 2021$63,000
+50.0%
487
-6.2%
0.00%
Q1 2021$42,000
+5.0%
519
+4.8%
0.00%
Q4 2020$40,0004950.00%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
MWG Management Ltd. 2,362,635$205,573,00024.93%
HSG Holding Ltd 796,089$69,268,0006.22%
DC Investments Management, LLC 21,010$1,828,0003.41%
Redmile Group, LLC 1,975,006$171,845,0003.00%
Casdin Capital, LLC 818,820$71,246,0001.77%
Evolutionary Tree Capital Management, LLC 44,390$3,862,0001.71%
HHLR ADVISORS, LTD. 1,448,161$126,004,0001.65%
Nan Fung Group Holdings Ltd 54,903$4,777,0001.53%
ARK Investment Management 6,841,722$595,298,0001.43%
BRANDYWINE MANAGERS, LLC 12,900$1,122,0001.17%
View complete list of BEAM THERAPEUTICS INC shareholders